Park Avenue Securities LLC Purchases 1,069 Shares of CME Group Inc (CME)

Park Avenue Securities LLC increased its holdings in shares of CME Group Inc (NASDAQ:CME) by 19.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,566 shares of the financial services provider’s stock after purchasing an additional 1,069 shares during the period. Park Avenue Securities LLC’s holdings in CME Group were worth $1,186,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. BP PLC increased its stake in CME Group by 2.2% during the third quarter. BP PLC now owns 102,200 shares of the financial services provider’s stock valued at $17,396,000 after purchasing an additional 2,200 shares during the last quarter. Steward Partners Investment Advisory LLC increased its holdings in shares of CME Group by 42.8% in the 3rd quarter. Steward Partners Investment Advisory LLC now owns 16,471 shares of the financial services provider’s stock valued at $2,804,000 after purchasing an additional 4,939 shares during the period. Nisa Investment Advisors LLC increased its holdings in CME Group by 13.4% in the third quarter. Nisa Investment Advisors LLC now owns 122,863 shares of the financial services provider’s stock worth $20,912,000 after buying an additional 14,534 shares during the last quarter. Chartwell Investment Partners LLC increased its holdings in CME Group by 60.3% in the third quarter. Chartwell Investment Partners LLC now owns 39,284 shares of the financial services provider’s stock worth $6,687,000 after buying an additional 14,770 shares during the last quarter. Finally, Peregrine Capital Management LLC boosted its position in CME Group by 2.5% during the fourth quarter. Peregrine Capital Management LLC now owns 92,984 shares of the financial services provider’s stock worth $17,492,000 after purchasing an additional 2,267 shares during the period. Institutional investors own 90.59% of the company’s stock.

Shares of CME opened at $180.40 on Thursday. The company has a market cap of $60.81 billion, a P/E ratio of 37.82, a price-to-earnings-growth ratio of 2.18 and a beta of 0.30. CME Group Inc has a 12 month low of $153.90 and a 12 month high of $197.08. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.09.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 25th. Investors of record on Friday, March 8th will be paid a dividend of $0.75 per share. This is a positive change from CME Group’s previous quarterly dividend of $0.70. The ex-dividend date is Thursday, March 7th. This represents a $3.00 annualized dividend and a yield of 1.66%. CME Group’s dividend payout ratio (DPR) is currently 58.70%.

Several research firms have recently weighed in on CME. Zacks Investment Research cut CME Group from a “buy” rating to a “hold” rating in a research report on Friday, December 7th. Bank of America reiterated a “neutral” rating and set a $191.00 price objective (down from $200.00) on shares of CME Group in a research note on Friday, January 11th. They noted that the move was a valuation call. UBS Group lowered CME Group from a “buy” rating to a “neutral” rating and raised their target price for the company from $185.00 to $204.00 in a research note on Wednesday, November 28th. Berenberg Bank upgraded CME Group from a “hold” rating to a “buy” rating and set a $220.00 price target on the stock in a report on Tuesday, November 20th. Finally, BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, January 9th. Nine investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $195.21.

In other CME Group news, CFO John W. Pietrowicz sold 17,960 shares of the company’s stock in a transaction that occurred on Wednesday, January 2nd. The stock was sold at an average price of $186.92, for a total transaction of $3,357,083.20. Following the transaction, the chief financial officer now owns 44,780 shares in the company, valued at approximately $8,370,277.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Julie Winkler sold 5,847 shares of the company’s stock in a transaction that occurred on Friday, November 16th. The stock was sold at an average price of $195.01, for a total value of $1,140,223.47. Following the transaction, the insider now owns 24,255 shares in the company, valued at approximately $4,729,967.55. The disclosure for this sale can be found here. Insiders have sold 52,494 shares of company stock valued at $9,967,852 in the last three months. 0.43% of the stock is owned by corporate insiders.

TRADEMARK VIOLATION NOTICE: This report was posted by Baseball Daily News and is owned by of Baseball Daily News. If you are reading this report on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright laws. The original version of this report can be viewed at https://www.baseballdailydigest.com/news/2019/02/14/park-avenue-securities-llc-has-1-19-million-holdings-in-cme-group-inc-cme.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Read More: Insider Trading – What You Need to Know

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply